Clarient, Inc. (CLRT.O)

CLRT.O on Consolidated Issue listed on NASDAQ Capital Market

2.37USD
4:00pm EST
Price Change (% chg)

$0.04 (+1.72%)
Prev Close
$2.33
Open
$2.33
Day's High
$2.41
Day's Low
$2.30
Volume
421,694
Avg. Vol
1,078,086
52-wk High
$4.43
52-wk Low
$1.00

CLRT.O

Chart for CLRT.O

About

Clarient, Inc. (Clarient) is an oncology diagnostics services company. The Company delivers oncology diagnostic testing services to community pathologists, biopharmaceutical companies, and researchers. As of December 31, 2008, all of the Company's services were provided within the United States, and substantially all of the... (more)

Overall

Beta: 0.77
Market Cap (Mil.): $182.74
Shares Outstanding (Mil.): 78.43
Annual Dividend: 0.00
Yield (%): NA

Financials

  CLRT.O Industry Sector
P/E (TTM): -- 10.56 4.61
EPS (TTM): 7.88 -- --
ROI: -33.45 4.16 2.81
ROE: -- 8.48 4.10
view overview for:

Latest News about CLRT.O

UPDATE 1-Clarient posts Q4 loss; gets going concern warning

March 31 (Reuters) - Clarient Inc , a cancer treatment services provider, posted a wider quarterly loss, and said auditors raised concerns over the company's ability to continue as a going concern.

31 Mar 2008

CombiMatrix, Clarient to market and sell cancer test

Jan 31 (Reuters) - CombiMatrix Corp and Clarient Inc said they would jointly market and sell a cancer test called HemeScan.

31 Jan 2008

Clarient Inc Q3 results

CLARIENT INC : * Third quarter loss per share $0.04 from continuing operations * Third quarter revenue from continuing operations rose 52 percent to $12.1 million * Reuters Estimates third quarter earnings per share view $-0.03, revenue view $11.34 million

30 Oct 2007
» More CLRT.O News

Competitors

  Price Change
Quest Diagnostics Incorporated (DGX.N) $61.44 +1.01
Laboratory Corp. of America Holdings (LH.N) $74.75 +0.94

  Earnings  vs    Estimates

view overview for: